Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjebo F C Heeren

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Retina (Philadelphia, Pa.)|December 20, 2013
First symptoms and their age of onset in macular telangiectasia type 2Tjebo F C Heeren, Frank G Holz, Peter Charbel Issa
Journal of Ophthalmology|July 24, 2023
A Novel Role for Corneal Pachymetry in Planning Cataract Surgery by Determining Changes in Spherical Equivalent Resulting from a Previous LASIK TreatmentArthur Hammer, Tjebo F C Heeren, Romesh Angunawela, et al.
Retina (Philadelphia, Pa.)|September 5, 2015
POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2Elke H Kupitz, Tjebo F C Heeren, Frank G Holz, et al.
Developments in Ophthalmology|October 27, 2015
Treatment for Macular Telangiectasia Type 2Peter Charbel Issa, Elke H Kupitz, Tjebo F C Heeren, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 24, 2015
In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imagingArno P Göbel, Monika Fleckenstein, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|January 13, 2021
HYPERREFLECTIVITY ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2Simone Tzaridis, Kristina Hess, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|November 24, 2020
WITHDRAWN: Hyper-reflectivity on optical coherence tomography in macular telangiectasia type 2Simone Tzaridis, Kristina Hess, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|June 28, 2017
EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2Mali Okada, Tjebo F C Heeren, Catherine A Egan, et al.
Retina (Philadelphia, Pa.)|August 24, 2017
MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the DiseaseMali Okada, Catherine A Egan, Tjebo F C Heeren, et al.
American Journal of Ophthalmology|July 28, 2018
Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2Simone Müller, Peter Charbel Issa, Tjebo F C Heeren, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Retina (Philadelphia, Pa.)|December 20, 2013
First symptoms and their age of onset in macular telangiectasia type 2Tjebo F C Heeren, Frank G Holz, Peter Charbel Issa
Journal of Ophthalmology|July 24, 2023
A Novel Role for Corneal Pachymetry in Planning Cataract Surgery by Determining Changes in Spherical Equivalent Resulting from a Previous LASIK TreatmentArthur Hammer, Tjebo F C Heeren, Romesh Angunawela, et al.
Retina (Philadelphia, Pa.)|September 5, 2015
POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2Elke H Kupitz, Tjebo F C Heeren, Frank G Holz, et al.
Developments in Ophthalmology|October 27, 2015
Treatment for Macular Telangiectasia Type 2Peter Charbel Issa, Elke H Kupitz, Tjebo F C Heeren, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 24, 2015
In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imagingArno P Göbel, Monika Fleckenstein, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|January 13, 2021
HYPERREFLECTIVITY ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2Simone Tzaridis, Kristina Hess, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|November 24, 2020
WITHDRAWN: Hyper-reflectivity on optical coherence tomography in macular telangiectasia type 2Simone Tzaridis, Kristina Hess, Tjebo F C Heeren, et al.
Retina (Philadelphia, Pa.)|June 28, 2017
EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2Mali Okada, Tjebo F C Heeren, Catherine A Egan, et al.
Retina (Philadelphia, Pa.)|August 24, 2017
MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the DiseaseMali Okada, Catherine A Egan, Tjebo F C Heeren, et al.
American Journal of Ophthalmology|July 28, 2018
Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2Simone Müller, Peter Charbel Issa, Tjebo F C Heeren, et al.
Pageof 5